Stock Events

Stock Events

Halozyme Therapeutics (HALO) Q4 2017 Earnings

7NovConfirmed

Q1 2017

Q2 2017

Q3 2017

Q4 2017

-0.27

-0.17

-0.08

0.02

Details

Expected EPS

-0.01

Actual EPS

0.02

Surprise EPS

0.03

Surprise Percent

+300%

Description

Halozyme Therapeutics (HALO) has reported earnings of 0.02 per share for Q4 2017.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.